Di Perna F - Search Results

1

Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone.

Cazzola M, Noschese P, Di Perna F. Cazzola M, et al. Among authors: di perna f. Ther Adv Respir Dis. 2009 Apr;3(2):59-63. doi: 10.1177/1753465809104677. Epub 2009 May 14. Ther Adv Respir Dis. 2009. PMID: 19443519 Free article. Clinical Trial.

2

A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease.

Cazzola M, Matera MG, Di Perna F, Calderaro F, Califano C, Vinciguerra A. Cazzola M, et al. Among authors: di perna f. Respir Med. 1998 Feb;92(2):354-7. doi: 10.1016/s0954-6111(98)90121-4. Respir Med. 1998. PMID: 9616538 Free article. Clinical Trial.

3

Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.

Cazzola M, Di Perna F, Noschese P, Vinciguerra A, Calderaro F, Girbino G, Matera MG. Cazzola M, et al. Among authors: di perna f. Eur Respir J. 1998 Jun;11(6):1337-41. doi: 10.1183/09031936.98.11061337. Eur Respir J. 1998. PMID: 9657576 Free article. Clinical Trial.

4

Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary disease.

Cazzola M, Vinciguerra A, Di Perna F, Matera MG. Cazzola M, et al. Among authors: di perna f. Respir Med. 1998 Aug;92(8):1012-6. doi: 10.1016/s0954-6111(98)90347-x. Respir Med. 1998. PMID: 9893768 Free article. Clinical Trial.

5

Additive effects of salmeterol and fluticasone or theophylline in COPD.

Cazzola M, Di Lorenzo G, Di Perna F, Calderaro F, Testi R, Centanni S. Cazzola M, et al. Among authors: di lorenzo g, di perna f. Chest. 2000 Dec;118(6):1576-81. doi: 10.1378/chest.118.6.1576. Chest. 2000. PMID: 11115442 Clinical Trial.

6

Acute effects of higher than customary doses of salmeterol and salbutamol in patients with acute exacerbation of COPD.

Cazzola M, Califano C, Di Perna F, D'Amato M, Terzano C, Matera MG, D'Amato G, Marsico SA. Cazzola M, et al. Among authors: di perna f. Respir Med. 2002 Oct;96(10):790-5. doi: 10.1053/rmed.2002.1353. Respir Med. 2002. PMID: 12412978 Free article. Clinical Trial.

7

Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia.

Cazzola M, Imperatore F, Salzillo A, Di Perna F, Calderaro F, Imperatore A, Matera MG. Cazzola M, et al. Among authors: di perna f. Chest. 1998 Aug;114(2):411-5. doi: 10.1378/chest.114.2.411. Chest. 1998. PMID: 9726723 Clinical Trial.

8

Incremental benefit of adding oxitropium bromide to formoterol in patients with stable COPD.

Cazzola M, Di Perna F, Califano C, Vinciguerra A, D'Amato M. Cazzola M, et al. Among authors: di perna f. Pulm Pharmacol Ther. 1999;12(4):267-71. doi: 10.1006/pupt.1999.0208. Pulm Pharmacol Ther. 1999. PMID: 10501652 Clinical Trial.

9

Formoterol Turbuhaler for as-needed therapy in patients with mild acute exacerbations of COPD.

Cazzola M, Di Perna F, D'Amato M, Califano C, Matera MG, D'Amato G. Cazzola M, et al. Among authors: di perna f. Respir Med. 2001 Nov;95(11):917-21. doi: 10.1053/rmed.2001.1172. Respir Med. 2001. PMID: 11716207 Free article. Clinical Trial.

10

A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease.

Matera MG, Cazzola M, Vinciguerra A, Di Perna F, Calderaro F, Caputi M, Rossi F. Matera MG, et al. Among authors: di perna f. Pulm Pharmacol. 1995 Dec;8(6):267-71. doi: 10.1006/pulp.1995.1036. Pulm Pharmacol. 1995. PMID: 8819181 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters